Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Oxford Immunotec Global PLC    OXFD   GB00BGFBB958

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/16/2017 11/17/2017 11/20/2017 11/21/2017 11/22/2017 Date
13.51(c) 13.5(c) 13.71(c) 14.01(c) 14.25(c) Last
156 234 86 595 176 111 255 249 146 336 Volume
+4.40% -0.07% +1.56% +2.19% +1.71% Change
More quotes
Financials ($)
Sales 2017 104 M
EBIT 2017 -41,9 M
Net income 2017 -50,3 M
Finance 2017 25,0 M
Yield 2017 -
Sales 2018 120 M
EBIT 2018 -24,6 M
Net income 2018 -27,0 M
Finance 2018 2,96 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 3,27x
EV / Sales2018 3,02x
Capitalization 366 M
More Financials
Company
Oxford Immunotec Global Plc is a medical diagnostics company, which engages in the developing and commercializing of proprietary tests for under-served immune-regulated conditions.Its current product lines and development activities principally focus on four areas: infectious diseases,... 
More about the company
Surperformance© ratings of Oxford Immunotec Global PL
Trading Rating : Investor Rating :
More Ratings
Latest news on OXFORD IMMUNOTEC GLOBAL PL
10/31 OXFORD IMMUNOTEC GLOBAL PLC : to Host Earnings Call
09/27 Oxford Immunotec Announces Update in Patent Infringement Litigation
08/30 Oxford Immunotec to Present at the Baird 2017 Global Healthcare Conference
08/15 Oxford Immunotec Global PLC Announces Pricing of Underwritten Public Offering..
08/14 Oxford Immunotec Global PLC Announces Agreement to Sell 2,500,000 Ordinary Sh..
08/01 OXFORD IMMUNOTEC GLOBAL PLC : Investor Network: Oxford Immunotec Global PLC to H..
06/22 Oxford Immunotec Announces National Reimbursement for the T-SPOT®.TB Test in ..
06/05 Oxford Immunotec Names Karen Koski Head of Strategy and Investor Relations
05/02 OXFORD IMMUNOTEC GLOBAL PLC : Investor Network: Oxford Immunotec Global PLC to H..
03/23 Oxford Immunotec Announces Release of New National Tuberculosis Test Data and..
More news
Sector news : Medical Diagnostic & Testing Equipment
08:33aDJROYAL PHILIPS : Philips Buys U.S. Startup Analytical Informatics
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/12 FISHER & PAYKEL HEALTHCARE : & Paykel says UK court rules rival Resmed's patent ..
10/30DJROYAL PHILIPS : Correction to Philips Share Buyback Article
10/30DJROYAL PHILIPS : Philips Launches EUR150 Million Share Buyback for Employee Stock..
More sector news : Medical Diagnostic & Testing Equipment
News from SeekingAlpha
10/31 Oxford Immunotec Global's (OXFD) CEO Peter Wrighton-Smith on Q3 2017 Results ..
10/31 Oxford Immunotec Q3 top line up 17%; non-GAAP EBITDA down 16%; softer guidanc..
10/31 Midday Gainers / Losers
10/31 Oxford Immunotec Global EPS of -$0.70
09/28 Premarket analyst action - healthcare
Chart OXFORD IMMUNOTEC GLOBAL PL
Duration : Period :
Oxford Immunotec Global PL Technical Analysis Chart | OXFD | GB00BGFBB958 | 4-Traders
Technical analysis trends OXFORD IMMUNOTEC GLOBAL PL
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 19,8 $
Spread / Average Target 39%
EPS Revisions
Managers
NameTitle
Peter James Wrighton-Smith Chief Executive Officer & Executive Director
Richard Alvin Sandberg Chairman
Stefan C. Linn Chief Operating Officer
Richard M. Altieri CFO & Principal Accounting Officer
Richard J. Wenstrup Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
OXFORD IMMUNOTEC GLOBAL PLC-4.68%366
SARTORIUS AG (PREFERENCE)13.96%6 906
SARTORIUS AG5.73%6 906
MYRIAD GENETICS, INC.97.18%2 276
VAREX IMAGING CORP0.00%1 384
NH SPECIAL PURPOSE ACQTN 2ND CO LTD--.--%403